E-LIB Suche - Ergebnisse für: Vivancos, María Jesús

1

Early Detection of Cancer and Precancerous Lesions in Perso..:

Gutiérrez, Félix ; López, Leandro ; Galera, Carlos...
Clinical Infectious Diseases. , 2024

2

Bictegravir/emtricitabine/tenofovir alafenamide as first-li..:

Hidalgo-Tenorio, Carmen ; Sequera, Sergio ; Vivancos, María Jesus...
International Journal of Antimicrobial Agents. 63 (2024) 6 - p. 107164 , 2024

Link: https://doi.org/10.1016/..

3

Transition times across the HIV care continuum in Spain fro..:

García-Ruiz de Morales, Alejandro G ; Vivancos, María Jesús ; de Lagarde, María...
The Lancet HIV. 11 (2024) 7 - p. e470-e478 , 2024

Link: https://doi.org/10.1016/..

4

Recently acquired hepatitis C: Epidemiological characterist..:

Martín-Carbonero, Luz ; Gutierrez, Ángela ; Bisbal, Otilia...
Enfermedades infecciosas y microbiologia clinica (English ed.). , 2023

Link: https://doi.org/10.1016/..

5

Global DNA methylation and telomere length as markers of ac..:

Moreno, Elena ; Martínez-Sanz, Javier ; Martín-Mateos, Rosa...
BMC Genomics. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

Switching to bictegravir/emtricitabine/tenofovir alafenamid..:

Podzamczer, Daniel ; Imaz, Arkaitz ; Lopez-Lirola, Ana...
Journal of Antimicrobial Chemotherapy. 78 (2023) 11 - p. 2696-2701 , 2023

Link: https://doi.org/10.1093/..

7

Effectiveness and safety of integrase strand transfer inhib..:

Santos, José Ramón ; Casadellà, Maria ; Noguera-Julian, Marc...
Frontiers in Cellular and Infection Microbiology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

Management of Comorbidities in Treated HIV Infection: A Lon..:

Martínez-Sanz, Javier ; Serrano-Villar, Sergio ; Vivancos, María Jesús..
International Journal of Antimicrobial Agents. 59 (2022) 1 - p. 106493 , 2022

Link: https://doi.org/10.1016/..

9

Fecal microbiota transplantation in HIV: A pilot placebo-co..:

Serrano-Villar, Sergio ; Talavera-Rodríguez, Alba ; Gosalbes, María José...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

10

Hepatitis C and HIV combined screening in primary care: A c..:

Martínez‐Sanz, Javier ; Vivancos, María Jesús ; Sánchez‐Conde, Matilde...
Journal of Viral Hepatitis. 28 (2020) 2 - p. 345-352 , 2020

Link: https://doi.org/10.1111/..

11

Randomized Trial Evaluating the Neurotoxicity of Dolutegrav..:

Perez Valero, Ignacio ; Cabello, Alfonso ; Ryan, Pablo...
Open Forum Infectious Diseases. 7 (2020) 12 - p. , 2020

Link: https://doi.org/10.1093/..

12

Maraviroc reactivates HIV with potency similar to that of o..:

López-Huertas, María Rosa ; Jiménez-Tormo, Laura ; Madrid-Elena, Nadia...
Biochemical Pharmacology. 182 (2020) - p. 114231 , 2020

Link: https://doi.org/10.1016/..

13

Impact of a structured HIV testing program in a hospital em..:

Gómez-Ayerbe, Cristina ; Martínez-Sanz, Javier ; Muriel, Alfonso...
PLOS ONE. 14 (2019) 8 - p. e0220375 , 2019

Link: https://doi.org/10.1371/..

14

Risk of cancer in HIV-infected patients in Spain, 2004–2015..:

García-Abellán, Javier ; del Río, Lorena ; García, José A....
Enfermedades infecciosas y microbiologia clinica (English ed.). 37 (2019) 8 - p. 502-508 , 2019

Link: https://doi.org/10.1016/..

15

Relapse or reinfection after failing hepatitis C direct act..:

Cuypers, Lize ; Pérez, Ana Belén ; Chueca, Natalia...
PLOS ONE. 13 (2018) 7 - p. e0201268 , 2018

Link: https://doi.org/10.1371/..